{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:36:02Z","timestamp":1768368962667,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Project of Science and Technology of Xiamen City","award":["3502Z20224015"],"award-info":[{"award-number":["3502Z20224015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03535-x","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T13:44:59Z","timestamp":1765115099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EPDR1 promotes gastric cancer progression via STAT3-mediated fatty acid metabolic reprogramming"],"prefix":"10.1186","volume":"31","author":[{"given":"Xinyou","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongkai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiquan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"3535_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M, Ni Y, Lu Z, Sun X, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut. 2021;70:464\u201375.","journal-title":"Gut"},{"key":"3535_CR2","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/S0140-6736(17)32131-1","volume":"390","author":"I Chau","year":"2017","unstructured":"Chau I. Checkpoint inhibition: an ATTRACTION in advanced gastric cancer? Lancet. 2017;390:2418\u20139.","journal-title":"Lancet"},{"key":"3535_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749\u201368.","journal-title":"JAMA Oncol"},{"key":"3535_CR4","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29:2452\u201368.","journal-title":"World J Gastroenterol"},{"key":"3535_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/104454901753340613","volume":"20","author":"J Apostolopoulos","year":"2001","unstructured":"Apostolopoulos J, Sparrow RL, McLeod JL, Collier FM, Darcy PK, Slater HR, et al. Identification and characterization of a novel family of mammalian ependymin-related proteins (MERPs) in hematopoietic, nonhematopoietic, and malignant tissues. DNA Cell Biol. 2001;20:625\u201335.","journal-title":"DNA Cell Biol"},{"key":"3535_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101629","volume":"66","author":"LR Cataldo","year":"2022","unstructured":"Cataldo LR, Gao Q, Argemi-Muntadas L, Hodek O, Cowan E, Hladkou S, et al. The human batokine EPDR1 regulates \u03b2-cell metabolism and function. Mol Metab. 2022;66:101629.","journal-title":"Mol Metab"},{"key":"3535_CR7","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1038\/s41598-020-60476-7","volume":"10","author":"F Gimeno-Valiente","year":"2020","unstructured":"Gimeno-Valiente F, Riffo-Campos \u00c1L, Ayala G, Tarazona N, Gambardella V, Rodr\u00edguez FM, et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep. 2020;10:3723.","journal-title":"Sci Rep"},{"key":"3535_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09065","volume":"8","author":"OS El-Masry","year":"2022","unstructured":"El-Masry OS, Alamri AM, Alzahrani F, Alsamman K. ADAMTS14, ARHGAP22, and EPDR1 as potential novel targets in acute myeloid leukaemia. Heliyon. 2022;8:e09065.","journal-title":"Heliyon"},{"key":"3535_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12894-021-00843-2","volume":"21","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhang H, Liu Z, Zhao F, Liang G. EPDR1 is related to stages and metastasize in bladder cancer and can be used as a prognostic biomarker. BMC Urol. 2021;21:71.","journal-title":"BMC Urol"},{"key":"3535_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cmet.2019.10.001","volume":"30","author":"AS Deshmukh","year":"2019","unstructured":"Deshmukh AS, Peijs L, Beaudry JL, Jespersen NZ, Nielsen CH, Ma T, et al. Proteomics-based comparative mapping of the secretomes of human brown and white adipocytes reveals EPDR1 as a novel batokine. Cell Metab. 2019;30:963-975.e967.","journal-title":"Cell Metab"},{"key":"3535_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02295-2","volume":"19","author":"X Liu","year":"2021","unstructured":"Liu X, Liu C, Zhang A, Wang Q, Ge J, Li Q, et al. Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1. World J Surg Oncol. 2021;19:199.","journal-title":"World J Surg Oncol"},{"key":"3535_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, et al. Evolving cognition of the JAK\u2013STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8:204.","journal-title":"Signal Transduct Target Ther"},{"key":"3535_CR13","doi-asserted-by":"crossref","unstructured":"Golus M, Bugajski P, Chorbinska J, Krajewski W, Leminski A, Saczko J, et al. STAT3 and its pathways' dysregulation-underestimated role in urological tumors. Cells. 2022;11.","DOI":"10.20944\/preprints202208.0163.v1"},{"key":"3535_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cac2.12507","volume":"44","author":"C Liu","year":"2024","unstructured":"Liu C, Shen A, Song J, Cheng L, Zhang M, Wang Y, et al. LncRNA-CCAT5-mediated crosstalk between Wnt\/beta-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity. Cancer Commun Lond. 2024;44:76\u2013100.","journal-title":"Cancer Commun Lond"},{"key":"3535_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis. 2022;13:630.","journal-title":"Cell Death Dis"},{"key":"3535_CR16","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1078-0432.CCR-04-0487","volume":"11","author":"W Gong","year":"2005","unstructured":"Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res. 2005;11:1386\u201393.","journal-title":"Clin Cancer Res"},{"key":"3535_CR17","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.7150\/ijbs.81972","volume":"19","author":"Z Ma","year":"2023","unstructured":"Ma Z, Sun Q, Zhang C, Zheng Q, Liu Y, Xu H, et al. RHOJ induces epithelial-to-mesenchymal transition by IL-6\/STAT3 to promote invasion and metastasis in gastric cancer. Int J Biol Sci. 2023;19:4411\u201326.","journal-title":"Int J Biol Sci"},{"key":"3535_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-022-04747-3","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Li H, Zhang H, Zhou H, Jiao T, Feng M, et al. RBMS1 promotes gastric cancer metastasis through autocrine IL-6\/JAK2\/STAT3 signaling. Cell Death Dis. 2022;13:287.","journal-title":"Cell Death Dis"},{"key":"3535_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1440-1746.2008.05671.x","volume":"24","author":"DY Kim","year":"2009","unstructured":"Kim DY, Cha ST, Ahn DH, Kang HY, Kwon CI, Ko KH, et al. STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol. 2009;24:646\u201351.","journal-title":"J Gastroenterol Hepatol"},{"key":"3535_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P. Metabolic reprogramming, sensing, and cancer therapy. Cell Rep. 2024;43:115064.","journal-title":"Cell Rep"},{"key":"3535_CR21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tibs.2018.04.006","volume":"43","author":"J Xiong","year":"2018","unstructured":"Xiong J. Fatty acid oxidation in cell fate determination. Trends Biochem Sci. 2018;43:854\u20137.","journal-title":"Trends Biochem Sci"},{"key":"3535_CR22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang K, Wang X, Song C, He Z, Wang R, Xu Y, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023;13:1774\u2013808.","journal-title":"Theranostics"},{"key":"3535_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227\u201332.","journal-title":"Nat Rev Cancer"},{"key":"3535_CR24","doi-asserted-by":"publisher","first-page":"G483","DOI":"10.1152\/ajpgi.00281.2023","volume":"326","author":"Y Lu","year":"2024","unstructured":"Lu Y, George J. Interaction between fatty acid oxidation and ethanol metabolism in liver. Am J Physiol Gastrointest Liver Physiol. 2024;326:G483-94.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3535_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM, Guo C, Wang W, Wang XY, et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100.","journal-title":"Cancer Lett"},{"key":"3535_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"3535_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Mart\u00edn M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41\u20135.","journal-title":"Nature"},{"key":"3535_CR28","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1172\/JCI127201","volume":"129","author":"Y Cao","year":"2019","unstructured":"Cao Y. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest. 2019;129:3006\u201317.","journal-title":"J Clin Invest"},{"key":"3535_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1874091X00903010014","volume":"3","author":"B Ganss","year":"2009","unstructured":"Ganss B, Hoffmann W. Calcium-induced conformational transition of trout ependymins monitored by tryptophan fluorescence. Open Biochem J. 2009;3:14\u20137.","journal-title":"Open Biochem J"},{"key":"3535_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101629","volume":"66","author":"LR Cataldo","year":"2022","unstructured":"Cataldo LR, Gao Q, Argemi-Muntadas L, Hodek O, Cowan E, Hladkou S, et al. The human batokine EPDR1 regulates beta-cell metabolism and function. Mol Metab. 2022;66:101629.","journal-title":"Mol Metab"},{"key":"3535_CR31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"3535_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.21","volume":"8","author":"YA Wen","year":"2017","unstructured":"Wen YA, Xing X, Harris JW, Zaytseva YY, Mitov MI, Napier DL, et al. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 2017;8:e2593.","journal-title":"Cell Death Dis"},{"key":"3535_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216235","volume":"565","author":"Z Chen","year":"2023","unstructured":"Chen Z, Xu P, Wang X, Li Y, Yang J, Xia Y, et al. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer. Cancer Lett. 2023;565:216235.","journal-title":"Cancer Lett"},{"key":"3535_CR34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-022-05436-x","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Yang C, Xiang Z, Huang G, Wu H, Chen T, et al. LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. Cell Death Dis. 2022;13:987.","journal-title":"Cell Death Dis"},{"key":"3535_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.132","volume":"7","author":"Q Qu","year":"2016","unstructured":"Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7:e2226.","journal-title":"Cell Death Dis"},{"key":"3535_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01201","volume":"9","author":"S Han","year":"2019","unstructured":"Han S, Wei R, Zhang X, Jiang N, Fan M, Huang JH, et al. CPT1A\/2-mediated FAO enhancement-a metabolic target in radioresistant breast cancer. Front Oncol. 2019;9:1201.","journal-title":"Front Oncol"},{"key":"3535_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41419-023-06220-1","volume":"14","author":"KG Zhu","year":"2023","unstructured":"Zhu KG, Yang J, Zhu Y, Zhu Q, Pan W, Deng S, et al. The microprotein encoded by exosomal lncAKR1C2 promotes gastric cancer lymph node metastasis by regulating fatty acid metabolism. Cell Death Dis. 2023;14:708.","journal-title":"Cell Death Dis"},{"key":"3535_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd7459","author":"N Oatman","year":"2021","unstructured":"Oatman N, Dasgupta N, Arora P, Choi K, Gawali MV, Gupta N, et al. Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancer. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abd7459.","journal-title":"Sci Adv"},{"key":"3535_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","volume":"30","author":"P Sansone","year":"2012","unstructured":"Sansone P, Bromberg J. Targeting the interleukin-6\/Jak\/stat pathway in human malignancies. J Clin Oncol. 2012;30:1005\u201314.","journal-title":"J Clin Oncol"},{"key":"3535_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0079-6107(98)00051-0","volume":"71","author":"K Shuai","year":"1999","unstructured":"Shuai K. The STAT family of proteins in cytokine signaling. Prog Biophys Mol Biol. 1999;71:405\u201322.","journal-title":"Prog Biophys Mol Biol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03535-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03535-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:22:03Z","timestamp":1768342923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03535-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3535"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03535-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the committee's guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients were informed and consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}